Erika Smith
CEO
business
Axerion Therapeutics
United States of America
Biography
More than 25 years of experience as an investor and entrepreneur in identifying, investing, managing and successfully exiting numerous seed and early-stage investments with funding from Yale and J & J.
Research Interest
investments with funding
